DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020
出版年份 2021 全文链接
标题
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-21
DOI
10.1007/s40257-021-00625-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases
- (2020) Juan A. Molina-Guarneros et al. International Journal of Clinical Pharmacy
- Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study
- (2020) M.S.M. Persson et al. BRITISH JOURNAL OF DERMATOLOGY
- Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey
- (2020) Phuc Le et al. DIABETES CARE
- Association Between Medication Use and Bullous Pemphigoid
- (2020) Sian-De Liu et al. JAMA Dermatology
- Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes
- (2019) Seon Gu Lee et al. JAMA Dermatology
- Case–non-case studies: Principle, methods, bias and interpretation
- (2019) Jean-Luc Faillie THERAPIE
- Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
- (2019) Antonios Douros et al. DIABETES CARE
- Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
- (2019) Kaisa Tasanen et al. Frontiers in Immunology
- Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®
- (2019) Carla Carnovale et al. Expert Opinion On Drug Safety
- Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors. A case series and analysis of cases reported in the Spanish pharmacovigilance database
- (2019) Alejandra Reolid et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database
- (2018) Masanori Arai et al. DIABETES CARE
- Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: a Finnish nationwide case control study
- (2018) O. Varpuluoma et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland
- (2018) Michael Benzaquen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review
- (2018) Patrick M. Jedlowski et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls
- (2017) B. Sim et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade
- (2017) L. Fania et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database
- (2016) J. Béné et al. BRITISH JOURNAL OF DERMATOLOGY
- Update on the pathogenesis of bullous pemphigoid: An autoantibody-mediated blistering disease targeting collagen XVII
- (2014) Wataru Nishie JOURNAL OF DERMATOLOGICAL SCIENCE
- Pemphigoid diseases
- (2012) Enno Schmidt et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started